Xu Zhengfan, Saikia Kasturi, Yuan Lisi
Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, MI, USA.
Gynecol Oncol Rep. 2023 Apr 13;47:101188. doi: 10.1016/j.gore.2023.101188. eCollection 2023 Jun.
•Dedifferentiated endometrial carcinoma arising from serous carcinoma (null-type P53).•Differential diagnosis including carcinosarcoma, FIGO grade 3 endometrioid carcinoma.•Also need to rule out SMARCA4-deficient uterine sarcoma and other sarcomas.
•由浆液性癌(P53 缺失型)引起的去分化子宫内膜癌。
•鉴别诊断包括癌肉瘤、国际妇产科联盟(FIGO)3 级子宫内膜样癌。
•还需要排除 SMARCA4 缺陷型子宫肉瘤和其他肉瘤。